Pre-Open Stock Movers:

Medallion Financial (NASDAQ: MFIN) 54% LOWER; SEC charged the company and its President and Chief Operating Officer, Andrew Murstein of New York, NY, with illegally engaging in two schemes in an effort to reverse the companys plummeting stock price.

Shares of TuSimple (NASDAQ: TSP) 15% HIGHER; announced it successfully completed the world's first fully autonomous semi-truck run on open public roads.

Shares of FuelCell Energy (NASDAQ: FCEL) 12.1% LOWER; reported a worse-than-expected loss. The company reported revenue of $13.9 million, down from $17 million. FCEL reported a loss of $22.6 million, up from the prior $17.1 million loss. Analysts were calling for revenue of $21.8 million.

Calix (NYSE: CALX) 9.4% HIGHER; will replace CIT Group Inc. (NYSE: CIT), effective prior to the opening of trading on Tuesday, January 4.

Codex DNA (NASDAQ: DNAY) 9.2% HIGHER; disclosed on December 22, 2021, the Company entered into a Research Collaboration and License Agreement with Pfizer Inc. (NYSE: PFE), pursuant to which the Company and Pfizer agreed to collaborate to develop improvements to the Companys existing proprietary BioXP platform including associated instruments, kits/reagents, workflows and other methods (such improved versions, the Improved Platform) and to use the Improved Platform to produce certain materials of interest to Pfizer (the Pfizer Outputs) (such activities, collectively, the R&D Program).

Orchard Therapeutics (NASDAQ: ORTX) 7.6% HIGHER; Cantor Fitzgerald assumes coverage with an Overweight rating and a price target of $9.00.

Victoria’s Secret (NYSE: VSCO) 7% HIGHER; announced that it launched an accelerated share buyback program. The company will work with Goldman Sachs to repurchase $250 million of its common stock. Moreover, VSCO reaffirmed its fourth quarter sales, operating income and earnings guidance.

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) 2.3% HIGHER; announced that its subsidiary, Oravax Medical, has signed a Cooperation and Purchase Agreement with Vietnam-based Tan Thanh Holdings Investment Joint Stock Company to pre-purchase Oravax's oral COVID-19 vaccine, currently in development. The agreement grants Tan Thanh Holdings the right to sell Oravax's oral vaccine in development throughout the Association of Southeast Asian Nations (ASEAN) which includes Vietnam, Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore and Thailand. The Agreement is for an initial pre-order of 10 million doses of oral COVID-19 vaccines from Oravax and is comprised of milestone payments. The parties have agreed to negotiate follow-on orders potentially worth hundreds of millions of dollars.

Shares of Rivian (NASDAQ: RIVN) 2.2% LOWER; will delay deliveries of its electric pickup truck and sports utility vehicles with bigger batteries to 2023.

Tesla (NASDAQ: TSLA) 1% HIGHER; CEO Elon Musk exercised all of his stock options that are due to expire next year.